These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 15659891)
1. Double-blind randomized controlled trial assessing the safety and efficacy of intravesical agents for ureteral stent symptoms after extracorporeal shockwave lithotripsy. Beiko DT; Watterson JD; Knudsen BE; Nott L; Pautler SE; Brock GB; Razvi H; Denstedt JD J Endourol; 2004 Oct; 18(8):723-30. PubMed ID: 15659891 [TBL] [Abstract][Full Text] [Related]
2. A novel drug eluting ureteral stent: a prospective, randomized, multicenter clinical trial to evaluate the safety and effectiveness of a ketorolac loaded ureteral stent. Krambeck AE; Walsh RS; Denstedt JD; Preminger GM; Li J; Evans JC; Lingeman JE; J Urol; 2010 Mar; 183(3):1037-42. PubMed ID: 20092835 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of pethidine, ketorolac, and lidocaine gel as analgesics for pain control in shockwave lithotripsy: A single-blinded randomized controlled trial. Hashem A; Ghobrial FK; Elbaset MA; Atwa AM; Fadallah M; Laymon M; El-Assmy A; Sheir KZ; Abol-Enein H Investig Clin Urol; 2019 Jul; 60(4):251-257. PubMed ID: 31294134 [TBL] [Abstract][Full Text] [Related]
4. Intranasal ketorolac tromethamine (SPRIX(R)) containing 6% of lidocaine (ROX-828) for acute treatment of migraine: safety and efficacy data from a phase II clinical trial. Pfaffenrath V; Fenzl E; Bregman D; Färkkila M Cephalalgia; 2012 Jul; 32(10):766-77. PubMed ID: 22711895 [TBL] [Abstract][Full Text] [Related]
5. Comparison of efficacy and bladder irritation symptoms among three different ureteral stents: a double-blind, prospective, randomized controlled trial. Lee JN; Kim BS Scand J Urol; 2015 Jun; 49(3):237-41. PubMed ID: 25428751 [TBL] [Abstract][Full Text] [Related]
6. Intravesical ropivacaine as a novel means of analgesia post-robot-assisted radical prostatectomy: a randomized, double-blind, placebo-controlled trial. Fuller A; Vanderhaeghe L; Nott L; Martin PR; Pautler SE J Endourol; 2013 Mar; 27(3):313-7. PubMed ID: 22967208 [TBL] [Abstract][Full Text] [Related]
7. A prospective, randomized, double-blinded placebo-controlled comparison of extended release oxybutynin versus phenazopyridine for the management of postoperative ureteral stent discomfort. Norris RD; Sur RL; Springhart WP; Marguet CG; Mathias BJ; Pietrow PK; Albala DM; Preminger GM Urology; 2008 May; 71(5):792-5. PubMed ID: 18339420 [TBL] [Abstract][Full Text] [Related]
8. Analgesia during extracorporeal shock wave lithotripsy using the Medstone STS lithotriptor: a randomized prospective study. Issa MM; El-Galley R; McNamara DE; Segall S Urology; 1999 Oct; 54(4):625-8. PubMed ID: 10510918 [TBL] [Abstract][Full Text] [Related]
9. Does Combination Therapy with Tamsulosin and Tolterodine Improve Ureteral Stent Discomfort Compared with Tamsulosin Alone? A Double-Blind, Randomized, Controlled Trial. Sivalingam S; Streeper NM; Sehgal PD; Sninsky BC; Best SL; Nakada SY J Urol; 2016 Feb; 195(2):385-90. PubMed ID: 26393904 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of intravesical ropivacaine injection on urinary symptoms following ureteral stenting: a randomized, controlled study. Sur RL; Haleblian GE; Cantor DA; Springhart WP; Albala DM; Preminger GM J Endourol; 2008 Mar; 22(3):473-8. PubMed ID: 18290733 [TBL] [Abstract][Full Text] [Related]
11. Percuflex Helical Ureteral Stents Significantly Reduce Patient Analgesic Requirements Compared to Control Stents. Chew BH; Rebullar KA; Harriman D; McDougall E; Paterson RF; Lange D J Endourol; 2017 Dec; 31(12):1321-1325. PubMed ID: 29048209 [TBL] [Abstract][Full Text] [Related]
12. Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation. Trattler W; McDonald M Cornea; 2007 Jul; 26(6):665-9. PubMed ID: 17592313 [TBL] [Abstract][Full Text] [Related]
13. [Topical administration of oxybutynin hydrochloride in women with urge incontinence. Results of a prospective randomized double-blind study]. Enzelsberger H; Kurz C; Helmer H; Mittermayer F Geburtshilfe Frauenheilkd; 1995 May; 55(5):240-3. PubMed ID: 7607378 [TBL] [Abstract][Full Text] [Related]
14. Effect of highly concentrated hyaluronic acid/chondroitin sulphate instillation on ureteric stent-induced discomfort after ureteroscopic lithotripsy: a multicentre randomised controlled pilot study. Jo JK; Kim JH; Kim KS; Chung JH; Kim YT; Choi HY; Song ES; Lee B; Lee SW BJU Int; 2018 Nov; 122(5):858-865. PubMed ID: 29772114 [TBL] [Abstract][Full Text] [Related]
15. Intravesical alkalinized lidocaine (PSD597) offers sustained relief from symptoms of interstitial cystitis and painful bladder syndrome. Nickel JC; Moldwin R; Lee S; Davis EL; Henry RA; Wyllie MG BJU Int; 2009 Apr; 103(7):910-8. PubMed ID: 19021619 [TBL] [Abstract][Full Text] [Related]
16. An in vivo porcine evaluation of the safety, bioavailability, and tissue penetration of a ketorolac drug-eluting ureteral stent designed to improve comfort. Chew BH; Davoudi H; Li J; Denstedt JD J Endourol; 2010 Jun; 24(6):1023-9. PubMed ID: 20367085 [TBL] [Abstract][Full Text] [Related]
17. A randomized clinical trial of lidocaine jelly for prevention of inadvertent retrograde stone migration during pneumatic lithotripsy of ureteral stone. Zehri AA; Ather MH; Siddiqui KM; Sulaiman MN J Urol; 2008 Sep; 180(3):966-8. PubMed ID: 18639268 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of 0.4% ketorolac tromethamine ophthalmic solution versus 0.5% ketorolac tromethamine ophthalmic solution after phacoemulsification and intraocular lens implantation. Sandoval HP; De Castro LE; Vroman DT; Solomon KD J Ocul Pharmacol Ther; 2006 Aug; 22(4):251-7. PubMed ID: 16910866 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of topical ketorolac tromethamine 0.4% for control of pain or discomfort associated with cataract surgery. Price MO; Price FW Curr Med Res Opin; 2004 Dec; 20(12):2015-9. PubMed ID: 15701218 [TBL] [Abstract][Full Text] [Related]
20. Assessment of vesicoureteral reflux in patients with self-retaining ureteral stents: implications for upper urinary tract instillation. Yossepowitch O; Lifshitz DA; Dekel Y; Ehrlich Y; Gur U; Margel D; Livne PM; Baniel J J Urol; 2005 Mar; 173(3):890-3. PubMed ID: 15711312 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]